0.00Open0.26Pre Close0 Volume15 Open Interest88.00Strike Price0.00Turnover380.47%IV14.43%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.26Extrinsic Value100Contract SizeAmericanOptions Type0.0858Delta0.0229Gamma296.65Leverage Ratio-2.6717Theta0.0000Rho25.44Eff Leverage0.0028Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet